Structural basis for 18-β-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor
Open Access
- 17 August 2015
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 36 (9) , 1145-1150
Abstract
Glyoxalase I (GLOI), a glutathione (GSH)-dependent enzyme, is overexpressed in tumor cells and related to multi-drug resistance in chemotherapy, making GLOI inhibitors as potential anti-tumor agents. But the most studied GSH analogs exhibit poor pharmacokinetic properties. The aim of this study was to discover novel non-GSH analog GLOI inhibitors and analyze their binding mechanisms. Mouse GLOI (mGLOI) was expressed in BL21 (DE3) pLysS after induction with isopropyl-β-D-1-thiogalactopyranoside and purified using AKTA FPLC system. An in vitro mGLOI enzyme assay was used to screen a small pool of compounds containing carboxyl groups. Crystal structure of the mGLOI-inhibitor complex was determined at 2.3 Å resolution. Molecular docking study was performed using Discovery Studio 2.5 software package. A natural compound 18-β-glycyrrhetinic acid (GA) and its derivative carbenoxolone were identified as potent competitive non-GSH analog mGLOI inhibitors with Ki values of 0.29 μmol/L and 0.93 μmol/L, respectively. Four pentacyclic triterpenes (ursolic acid, oleanolic acid, betulic acid and tripterine) showed weak activities (mGLOI inhibition ratio <25% at 10 μmol/L) and other three (maslinic acid, corosolic acid and madecassic acid) were inactive. The crystal structure of the mGLOI-GA complex showed that the carboxyl group of GA mimicked the γ-glutamyl residue of GSH by hydrogen bonding to the glutamyl sites (residues Arg38B, Asn104B and Arg123A) in the GSH binding site of mGLOI. The extensive van der Waals interactions between GA and the surrounding residues also contributed greatly to the binding of GA and mGLOI. This work demonstrates a carboxyl group to be an important functional feature of non-GSH analog GLOI inhibitors.Keywords
This publication has 37 references indexed in Scilit:
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- Curcumin Inhibits Glyoxalase 1—A Possible Link to Its Anti-Inflammatory and Anti-Tumor ActivityPLOS ONE, 2008
- The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase IProceedings of the National Academy of Sciences, 2008
- Structure of a glutathione conjugate bound to the active site of aldose reductaseProteins: Structure, Function, and Bioinformatics, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Glyoxalase I inhibitors in cancer chemotherapyBiochemical Society Transactions, 2003
- Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycationBiochemical Society Transactions, 2003
- Synthesis and activity of γ-(L-γ-azaglutamyl)-S-(p-bromobenzyl)-L-cysteinylglycine: A metabolically stable inhibitor of glyoxalase IBioorganic & Medicinal Chemistry Letters, 1999
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994
- Effects of baicalein, a flavonoid, and other anti-inflammatory agents on glyoxalase-I activity.Agricultural and Biological Chemistry, 1986